The emails, so many of them heartbreaking, have been flooding our inboxes. Mostly they're from young people - in their 30s or ...

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...

In 2021, the FDA approved of another injectable semaglutide, Wegovy, for chronic weight management in adults ... for whom ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

A newly NHS-approved weight loss drug, Mounjaro, is being blamed for the tragic death of a 58-year-old Scottish nurse after ...

Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the weight-loss drug Wegovy—last January ... Ford devours running podcasts, plans her ...

Wegovy: Approved for chronic weight management in adults with obesity or overweight conditions, in conjunction with a reduced ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...